Tag: Behind the Study

Behind the Study is a series of transcribed videos from researchers elaborating on their recent oncology-focused studies published in Oncotarget. Visit the Oncotarget YouTube channel for more insights from outstanding authors.

Oncotarget

Behind the Study: CrkL Required for Donor T Cell Migration

February 18, 2022

Dr. Mobin Karimi from Upstate Medical University at Syracuse describes the research behind a 2020 paper he co-authored that was published by Oncotarget, entitled, “CrkL is required for donor T cell… read more

Oncotarget

Behind the Study: Oncogenic Transformation and Iron Chelation

February 7, 2022

Dr. Stephany Veuger and Dr. Gina Abdelaal from Northumbria University describe their 2021 review published by Oncotarget, entitled, “Reversing oncogenic transformation with iron chelation” Listen to an audio version of this post Behind… read more

Oncotarget

Behind the Study: Prognostic Markers in Adrenocortical Carcinoma

January 24, 2022

Dr. Monica Varun Tyagi from the Department of Surgery and Stanford Cancer Institute discusses the research paper she co-authored that was published by Oncotarget, entitled, “GATA3 and APOBEC3B are prognostic markers… read more

Dr. Brian Van Tine and Dr. Charles Schutt from Washington University in St. Louis

Oncotarget

Behind the Study: Genomic, Neoantigen Evolution in Head, Neck Cancer

January 10, 2022

Dr. Brian Van Tine and Dr. Charles Schutt from Washington University in St. Louis discuss their 2021 research published by Oncotarget, entitled, “Genomic and neoantigen evolution from primary tumor to first metastases in… read more

Oncotarget

Behind the Study: Cholera Toxin and Age-associated Obesity

December 23, 2021

Dr. Susan Erdman from Massachusetts Institute of Technology (MIT) discusses the 2019 research paper she co-authored, entitled, “Consuming cholera toxin counteracts age-associated obesity.” Listen to an audio version of this post Behind… read more

Oncotarget

Behind the Study: Metformin and Rapamycin as Maintenance Therapy

December 13, 2021

Dr. Katherine Bever from Johns Hopkins University discusses a research paper she co-authored that was published by Oncotarget, “An exploratory study of metformin with or without rapamycin as maintenance therapy after… read more

Oncotarget

Behind the Study: P4HA1 Protein and Colorectal Cancer

November 22, 2021

Dr. Michael Roehrl from Memorial Sloan Kettering Cancer Center describes the research paper he co-authored that was published by Oncotarget on February 25, 2020, entitled, “Prolyl 4-hydroxylase alpha 1 protein expression risk-stratifies early… read more

Oncotarget

Behind the Study: Benzophenone-3 Promotion of Mammary Tumorigenesis

November 15, 2021

Dr. Richard Schwartz describes the 2020 research paper he co-authored that was published by Oncotarget, entitled, “Benzophenone-3 promotion of mammary tumorigenesis is diet-dependent.” Listen to an audio version of this post… read more

Oncotarget

Behind the Study: Populations of Cells Resistant to EMT

September 27, 2021

Dr. Herbert Levine and Dr. Mohit Kumar Jolly describe their research that was published by Oncotarget on July 7, 2020, entitled, “Epigenetic feedback and stochastic partitioning during cell division can drive resistance to EMT.” Listen… read more

Oncotarget

Behind the Study: Evaluations in TRAMP Prostate Cancer Model

September 20, 2021

Behind the Study is a series of transcribed videos from researchers elaborating on their oncology-focused studies published by Oncotarget. A new Behind the Study is released each Monday. Visit the Oncotarget YouTube channel for more… read more